Effects of dopamine and serotonin-releasing agents on methamphetamine discrimination and self-administration in rats

Psychopharmacology

Volumn 141, Issue 3, 1999, Pages 287-296

  Munzar, Patrik ^a,b   Baumann, Michael H ^a   Shoaib, Mohammed ^a,c   Goldberg, Steven R ^a  

^a NIDA Addiction Research Center   (United States)

^b MASARYK UNIVERSITY   (Czech Republic)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Dopamine; Drug discrimination; Fenfluramine; Methamphetamine; Phentermine; Rat; Self administration; Serotonin

Indexed keywords

DOPAMINE; FENFLURAMINE; METHAMPHETAMINE; PHENTERMINE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOPAMINE RELEASE; DRUG DEPENDENCE; DRUG DISCRIMINATION; DRUG SELF ADMINISTRATION; DRUG TOLERANCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE;

ANIMALS; DISCRIMINATION (PSYCHOLOGY); DOPAMINE AGONISTS; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FENFLURAMINE; MALE; METHAMPHETAMINE; PHENTERMINE; RATS; RATS, SPRAGUE-DAWLEY; SELF ADMINISTRATION; SEROTONIN AGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 0032967021     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050836     Document Type: Article

References (59)

1. Balcioglu A, Wurtman RJ (1998) Dexfenfluramine enhances striatal dopamine release in conscious rats via a serotoninergic mechanism. J Pharmacol Exp Ther 284:991-997
2. Benloucif S, Galloway MP (1991) Facilitation of dopamine release by serotonin agonists: studies with microdialysis. Eur J Pharmacol 200:1-8
3. Berger UV, Gu X F, Azmitia EC (1992) The substituted amphetamines 3,4-methylendioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine. Eur J Pharmacol 215:153-160
4. Brauer LH, Johanson C-E, Schuster CR, Rothman RB, de Wit H (1996) Evaluation of phentermine and fenfluramine, alone and in combination, in normal, healthy volunteers. Neuropsychopharmacology 14:233-241
5. Carroll ME, Lac ST (1997) Acquisition of IV amphetamine and cocaine self-administration in rats as a function of dose. Psychopharmacology 129:206-214
6. Cass WA (1997) Decreases in evoked overflow of dopamine in rat striatum after neurotoxic doses of methamphetamine. J Pharmacol Exp Ther 280:105-113
7. Cho AK, Kumagai Y (1994) Metabolism of amphetamine and other arylisopropylamines. In: Cho AK, Seigel DS (eds) Amphetamine and its analogs: psychopharmacology, toxicology, and abuse. Academic Press, San Diego, pp 43-77
8. Connolly HM, Crary JL, McGoon MD, Hensrud DD, Edwards BS, Edwards, WD, Schaff HV (1997) Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 337: 581-588
9. De La Garza R, Johanson CE (1987) Discriminative stimulus properties of intragastrically administered d-amphetamine and pentobarbital in rhesus monkeys. J Pharmacol Exp Ther 243: 955-962
10. DiChiara G, Tanda G, Cadoni C, Acquas E, Bassareo V, Carboni E (1998) Homologies and differences in the activation of drugs of abuse and a conventional reinforcer (food) on dopamine transmission: an interpretative framework of the mechanism of drug dependence. Adv Pharmacol 42:983-987
11. Evans SM, Johanson CE (1987) Amphetamine-like effects of anorectics and related compounds in pigeons. J Pharmacol Exp Ther 241:817-825
12. Fletcher PJ (1995) Effects of d-fenfluramine and metergoline on responding for conditioned reward and the response potentiating effect of nucleus accumbens d-amphetamine. Psychopharmacology 118:155-163
13. Fletcher PJ (1996) Injection of 5-HT into the nucleus accumbens reduces the effects of d-amphetamine on responding for conditioned reward. Psychopharmacology 126:62-69
14. Fracasso C, Guiso G, Confalonieri S, Bergami A, Garattini S, Caccia S (1995) Depletion and time-course of recovery of brain serotonin after repeated subcutaneous dexfenfluramine in the mouse. A comparison with the rat. Neuropharmacology 34:1653-1659
15. Gibb JW, Hanson GR, Johnson M (1994) Neurochemical mechanisms of toxicity. In: Cho AK, Seigel DS (eds) Amphetamine and its analogs: psychopharmacology, toxicology, and abuse. Academic Press, San Diego, pp 269-295
16. Glowa JR, Fantegrossi WE (1997) Effects of dopaminergic drugs on food-and cocaine-maintained responding. IV. Continuous cocaine infusions. Drug Alcohol Depend 45:71-79
17. Glowa JR, Rice KC, Matecka D, Rothman RB (1997) Phentermine/fenfluramine decreases cocaine self-administration in rhesus monkeys. NeuroReport 8:1347-1351
18. Griffiths RR, Winger G, Brady JV, Snell JD (1976) Comparison of behaviour maintained by infusions of eight phenethylamines in baboons. Psychopharmacology 50:251-256
19. 3 receptor antagonists and the indirect 5-HT agonist, dexfenfluramine, on heroin self-administration in rats. Psychopharmacology 114:611-619
20. Hitzig P (1993) Combined dopamine and serotonin agonists: a synergistic approach to alcoholism and other addictive disorders. Maryland Med J 42:153-156
21. Kleven MS, Seiden LS (1989) D-, L-and DL-fenfluramine cause long-lasting depletions of serotonin in rat brain. Brain Res 505:351-353
22. Koob GF (1992) Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13:177 -184
23. Kuczenski R, Segal DS, Cho AK, Melega W (1995) Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine. J Neurosci 15:1308-1317
24. Leccese AP, Lyness WH (1984) The effects of putative 5-hydroxytryptamine receptor active agents on D-amphetamine self-administration in controls and rats with 5,7-dihydroxytryptamine median forebrain bundle lesions. Brain Res 303:153-162
25. Locke KW, Levesque TR, Nicholson KL, Balster RL (1996) Dexfenfluramine lacks amphetamine-like abuse potential. Prog Neuropsychopharmacol Biol Psychiatry 20:1019-1035
26. Lu MR, Wagner GC, Fisher H (1993) Ethanol consumption following acute fenfluramine, fluoxetine, and dietary tryptophan. Pharmacol Biochem Behav 44:931-937
27. Lyness WH (1983) Effect of L-tryptophan pretreatment on D-amphetamine self-administration. Subst Alcohol Actions Misuse 4:305-312
28. Marona-Lewicka D, Rhee GS, Sprague JE, Nichols DE (1996) Reinforcing effects of certain serotonin-releasing amphetamine derivatives. Pharmacol Biochem Behav 53:99-105
29. Melega WP, Williams AE, Schmitz DA, DiStefano EW, Cho AK (1995) Pharmacokinetic and pharmacodynamic analysis of the actions of d-amphetamine and d-methamphetamine on the dopamine terminal. J Pharmacol Exp Ther 274:90-96
30. Munzar P, Goldberg SR, Schindler CW, Rothman RB, Shoaib M (1998) Effects of phentermine and fenfluramine on reacquisition of cocaine self-administration in rats. NIDA Res Monogr 178:140
31. National Research Council (1996) Guide for the care and use of laboratory animals. National Academy Press, Washington, D.C.
32. Olds ME (1995) Dopamine agonists prevent or counteract the suppression of brain stimulation reward by fenfluramine. Pharmacol Biochem Behav 50:41-48
33. Olds ME, Yuwiler A (1992) Effects of acute and chronic fenfluramine on self-stimulation and its facilitation by amphetamine. Eur J Pharmacol 216:363-372
34. Panlilio LV, Goldberg SR, Gilman JP, Jufer R, Cone EJ, Schindler CW (1998) Effects of delivery rate and noncontingent infusion of cocaine on cocaine self-administration in rhesus monkeys. Psychopharmacology 137:253-258
35. Papasava M, Singer G, Papasava, CL (1985) Phentermine self-administration in naive free-feeding and food-deprived rats: a dose response study. Psychopharmacology 85:410-413
36. Parsons LH, Justice JB (1993) Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res 606:195-199
37. Porrino LJ, Ritz MC, Goodman NL, Sharpe LG, Kuhar MJ, Goldberg SR (1989) Differential effects of the pharmacological manipulation of serotonin systems on cocaine and amphetamine self-administration in rats. Life Sci 45:1529-1535
38. Rea WP, Rothman RB, Baumann MH, Shippenberg TS (1997) The motivational effects of phentermine and fenfluramine in rats. Soc Neurosci Abstr 23:2143
39. Rothman RB, Gendron T, Hitzig P (1994) Letter to editor: combined use of fenfluramine and phentermine in the treatment of cocaine addiction: a pilot case series. J Subst Abuse Treat 11: 273-275
40. Rothman RB, Elmer GI, Shippenberg TS, Rea W, Baumann MH (1998) Phentermine and fenfluramine: preclinical studies in animal models of cocaine addiction. Ann NY Acad Sci 844: 59-74
41. Sasaki JE, Tatham TA, Barrett JE (1995) The discriminative stimulus effects of methamphetamine in pigeons. Psychopharmacology 120:303-310
42. Schechter MD, McBurney D (1996) Phentermine+fenfluramine produce cocaine-like discriminative cues. Life Sci 59:PL303-308
43. Schechter MD, Rosecrans JA (1973) D-Amphetamine as a discriminative cue: drugs with similar stimulus properties. Eur J Pharmacol 21:212-216
44. Schuldiner S, Steiner-Mordich S, Yelin R, Wall SC, Rudnick G (1993) Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters. Mol Pharmacol 44:1227-1231
45. Seiden LS, Sabol KE (1996) Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction. NIDA Res Monogr 163:251-276
46. Shoaib M, Schindler CW, Goldberg SR (1997a) Nicotine self-administration in rats: strain and nicotine pre-exposure effects on acquisition. Psychopharmacology 129:35-43
47. Shoaib M, Baumann MH, Rothman RB, Goldberg SR, Schindler CW (1997b) Behavioural and neurochemical characteristics of phentermine and fenfluramine administered separately and as a mixture in rats. Psychopharmacology 131:296-306
48. Suzuki T, Mori T, Tsuji M, Misawa M, Nagase H (1997) The role of delta-opioid receptors in the discriminative stimulus properties of a low dose of methamphetamine. Eur J Pharmacol 331:1-8
49. Swan S (1997) Response to escalating methamphetamine abuse builds on NIDA-founded research. NIDA Notes 11: 5-6, 18-19
50. Walsh SL, Cunningham KA (1997) Serotonergic mechanism involved in the discriminative stimulus, reinforcing and subjective effects of cocaine. Psychopharmacology 130:41-58
51. Wang Y, Joharchi N, Fletcher PJ, Sellers EM, Higgins GA (1995) Further studies to examine the nature of dexfenfluramine-induced suppression of heroin self-administration. Psychopharmacology 120:134-141
52. Weintraub M (1992) Long-term weight control study. Conclusions. Clin Pharmacol Ther 51:642-646
53. Winger GD, Yasar S, Negus SS, Goldberg SR (1994) Intravenous self-administration studies with 1-deprenyl (selegiline) in monkeys. Clin Pharmacol Ther 56:774-780
54. Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94:469-492
55. Wood DM, Emmett-Oglesby MW (1988) Substitution and cross-tolerance profiles of anorectic drugs in rats trained to detect the discriminative stimulus properties of cocaine. Psychopharmacology 95:364-368
56. Yasar S, Schindler CW, Thorndike EB, Szelenyi I, Goldberg SR (1993) Evaluation of the stereoisomers of deprenyl for amphetamine-like discriminative stimulus effects in rats. J Pharmacol Exp Ther 265:1-6
57. Yasar S, Bergman J (1994) Amphetamine-like effect of 1-deprenyl (selegiline) in drug discrimination studies. Clin Pharmacol Ther 56:768-773
58. Yeghiayan SK, Kelley AE, Kula NS, Campbell A, Baldessarini RJ (1997) Role of dopamine in behavioral effects of serotonin microinjected into rat striatum. Pharmacol Biochem Behav 56: 251-259
59. Yokel RA, Pickens R (1973) Self-administration of optical isomers of amphetamine and methylamphetamine by rats. J Pharmacol Exp Ther 187:27-33